학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 101건 | 목록 1~10
Academic Journal
Atkinson SJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Bagal SK; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Argyrou A; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Askin S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Cheung T; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Chiarparin E; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Coen M; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Collie IT; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dale IL; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; De Fusco C; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Dillman K; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Evans L; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Feron LJ; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Foster AJ; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Grondine M; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Kantae V; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont GM; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lamont S; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Lynch JT; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Nilsson Lill S; Data Sciences & Modelling, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.; Robb GR; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Saeh J; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Schimpl M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Scott JS; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Smith J; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Srinivasan B; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Tentarelli S; Oncology R&D, AstraZeneca, R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.; Vazquez-Chantada M; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Wagner D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Walsh JJ; Discovery Sciences R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Watson D; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.; Williamson B; Oncology R&D, AstraZeneca, The Discovery Centre, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge CB2 0AA, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Conference
Optical Fiber Communication Conference. Technical Digest Postconference Edition. Trends in Optics and Photonics Vol.37 (IEEE Cat. No. 00CH37079) Optical fiber communication Optical Fiber Communication Conference, 2000. 4:278-280 vol.4 2000
Academic Journal
De Fusco C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Börjesson U; Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-431 83, Sweden.; Cheung T; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Collie I; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Evans L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Narasimhan P; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Stubbs C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Vazquez-Chantada M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Wagner DJ; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Grondine M; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Sanders MG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Tentarelli S; Oncology R&D, AstraZeneca, Boston, Massachusetts 02451, United States.; Underwood E; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Argyrou A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Smith JM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Lynch JT; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Chiarparin E; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Robb G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.; Scott JS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Wang J; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Boston, USA. Electronic address: Jianyan.wang@astrazeneca.com.; Ottosson J; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Tentarelli S; Chemistry, Oncology R&D, AstraZeneca, Boston, USA.
Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE
Periodical
Bloomberg.com. 2/8/2024, pN.PAG-N.PAG. 1p.
Academic Journal
Doshi AS; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Cantin S; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Hernandez M; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Srinivasan S; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Tentarelli S; Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Griffin M; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Wang Y; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Pop-Damkov P; Drug Metabolism and Pharmacokinetics, Oncology R&D, Waltham, Massachusetts.; Prickett LB; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Kankkonen C; Discovery Sciences, R&D, AstraZeneca, Mölndal, Sweden.; Shen M; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Martin MS; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Wu S; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.; Castaldi MP; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts.; Ghadially H; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Varnes J; Global Portfolio and Project Management, Waltham, Massachusetts.; Gales S; Toxicology, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Toxicology, Oncology R&D, AstraZeneca, Boston, Massachusetts.; Henry D; Toxicology, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Toxicology, Oncology R&D, AstraZeneca, Boston, Massachusetts.; Hoover C; Safety Pathology, Oncology R&D, AstraZeneca, Boston, Massachusetts.; Mele DA; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Simpson I; Chemistry, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Gangl ET; Drug Metabolism and Pharmacokinetics, Oncology R&D, Waltham, Massachusetts.; Mlynarski SN; Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Finlay MRV; Chemistry, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Drew L; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Fawell SE; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Shao W; Projects, Oncology R&D, AstraZeneca, Boston, Massachusetts.; Schuller AG; Bioscience, Oncology R&D, AstraZeneca, Waltham, Massachusetts.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Report
Nonlinearity 37 (2024), no. 1, article number 015009, 48pp
Academic Journal
Jin B; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Gopalsamy A; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Peng B; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Sha L; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Tentarelli S; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.; Gingipalli L; Medicinal Chemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 2985193R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6904 (Electronic) Linking ISSN: 00223263 NLM ISO Abbreviation: J Org Chem Subsets: PubMed not MEDLINE; MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Tentarelli, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어